Penumbra, Inc. Common Stock

Afficher le graphique complet Full chart

Financials

Total de l'actif 1.53 B1.59 B1.67 B1.74 B1.83 B1.9 B Total du passif 382.25 M380.43 M380.86 M385.67 M398.92 M424.63 M Total des capitaux propres 1.15 B1.21 B1.29 B1.36 B1.43 B1.47 B Total du passif et des capitaux propres 1.53 B1.59 B1.67 B1.74 B1.83 B1.9 B Dette totale —————— Dette nette ——————

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend.

PEN

Financials

Penumbra, Inc. Common Stock

Nouvelles

Baron Health Care Fund Q1 2026 Portfolio Activity

Le titre de Penumbra atteint un plus haut sur 52 semaines à 328,69$

Diamond Hill Long-Short Strategy Q1 2026 Portfolio Movers: Gains, Drags, And Trades

Penumbra (PEN) Misses Q1 Earnings Estimates

ALC vs. PEN: Which Stock Should Value Investors Buy Now?

Les résultats de Penumbra sous surveillance alors que l’acquisition par Boston Scientific se profile

NovoCure Stock Shows Strength With RS Upgrade; Investors Should Watch For Next Entry

3 Reasons Why Penumbra (PEN) Is a Great Growth Stock

Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts

Meitav Investment House lance une offre publique d’achat sur Peninsula

Here's Why Penumbra (PEN) is a Strong Growth Stock

L’essai Penumbra montre des résultats améliorés pour l’embolie pulmonaire